Market Overview
The global phase-transfer
catalyst market is expected to witness significant growth during the forecast
period owing to its increasing application in pharmaceuticals and
agrochemicals. The growth of the global market is primarily driven due to the
extensive use of the product in green chemistry. The adoption of green
chemistry is increasing on the backdrop of its benefits such as reduced waste,
energy and water saving, low toxicity, and higher yields of chemicals.
Get Free Sample Copy@ https://www.marketresearchfuture.com/sample_request/7543
Key Players
·
Tokyo Chemical Industry Co., Ltd.
·
SACHEM Inc.
·
Nippon Chemical Industrial CO., LTD.
·
Dishman Group
·
PAT IMPEX
·
Tatva Chintan Pharma Chem Pvt. Ltd.
·
Central Drug House
·
Ottokemi
·
GFS Chemicals, Inc.
·
PACIFIC ORGANICS PVT Ltd
Market Segmentation
The Global Phase-Transfer
Catalyst Market has been segmented based on type, application, and region.
By type, the global market is
segmented into ammonium salts, phosphonium salts, and others. The others
segment includes crown ethers and cryptands. Among these, the ammonium salts
segment accounted for the largest market share in 2018 on account of their
extensive use in chemical synthesis. This is due to their low cost, easy
availability, and wide scope of application. Apart from this, they can be used
in cosmetics and laundry detergents.
Because of application, the
global market has been segmented into pharmaceuticals, agrochemicals, and
others. The pharmaceuticals segment is further sub-segmented into active
pharmaceuticals ingredients and drug formulation. The pharmaceuticals was the
dominant segment in 2018, on the backdrop of constant research to develop new
medicines.
Regional Analysis
The global market, by region, has
been segmented into five regions, namely Asia-Pacific, North America, Europe,
Latin America, and the Middle East & Africa.
Asia-Pacific emerged as the
fastest-growing regional market owing to the high demand for agrochemicals in
the agricultural industry in the region. Moreover, the growth of the
pharmaceuticals industry on account of the growing geriatric population and
increasing R&D are expected to fuel the regional market growth during the
forecast period. The North American and European markets are expected to
witness healthy growths due to expanding pharmaceutical base and increasing
investments related to R&D for new product development.
No comments:
Post a Comment